Progressive Corp. (0KOC)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 228.60 |
|---|---|
| 52-week range | 189.00 – 240.00 |
| Return, 1 month / 3 months | +11.1% / +11.5% |
| Return, 1 year / 3 years | +3.6% / +50.5% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 27.4% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 1.12M USD |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Progressive Corp. is an American insurance company based in Ohio that sells personal automobile insurance directly to drivers, along with homeowners, renters and commercial auto coverage. It markets its policies to individual consumers and small businesses, and it also provides insurance through independent agents. The company handles claims and customer service for its policyholders across the United States.
The shares are listed on the London Exchange in UK under the code 0KOC, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Progressive Corp. (0KOC) trades on the London Exchange in UK. It last closed at USD 228.60 on 22 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 931 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.6% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.5% | ||
| From 52-week high | -3.1% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 12.4% | ||
| 12-month return, skipping the last month | -6.7% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.3% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.12M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.9% |
|---|---|
| 1 month | +11.1% |
| 3 months | +11.5% |
| 6 months | +12.4% |
| 1 year | +3.6% |
| 3 years | +50.5% |
| 5 years | +155.7% |
Signals
| 50-day / 200-day average | 215.31 / 208.78 |
|---|---|
| Golden / death cross (60 days) | Golden, 55 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | USD 0.1000 |
| 1 Jul 2026 | USD 0.1000 |
| 1 Apr 2026 | USD 0.1000 |
| 31 Dec 2025 | USD 0.1000 |
| 1 Oct 2025 | USD 0.1000 |
| 2 Jul 2025 | USD 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.